Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 19.72% is 29% below its 1-year average of 27.86%, near the low end of its 1-year range (17.21%–36.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.90% below its 12-month average of 24.93%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.72%.
DEBT TO ASSETS RATIO
19.72%
DEBT TO ASSETS RATIO AVG TTM
24.93%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.90%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 732 covered companies
CURRENT VS SECTOR MEDIAN
+19623.42%
vs the sector median at left
BillionToOne, Inc.
Market Cap
$4.59B
Debt to Assets Ratio
19.72%
TTM Avg
24.93%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.69B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.72B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.43B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.42B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.37B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.85B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.86B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BillionToOne, Inc. (BLLN) | $4.59B | 19.72% | 24.93% | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 0.38% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 0.09% | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.72B | 0.03% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 0.41% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.42B | 0.64% | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.37B | 0.01% | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.85B | 0.00% | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | 0.00% | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.30B | 0.08% | N/A | N/A | N/A |
Debt/Assets
19.7%
Debt/Equity
0.27
Current Ratio
11.69
Interest Coverage
168.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 19.72% |
| 2026-03-31 | 20.58% |
| 2025-12-31 | 17.21% |
| 2025-09-30 | 33.02% |
| 2025-06-30 | 34.14% |
| 2025-03-31 | 34.14% |
| 2024-12-31 | 36.21% |
